-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
Science
Covid-19
-
National COVID-19 trends, September 10
-
“Perfect storm” of criminalization: Analyzing mask bans
-
National COVID-19 trends, September 3
-
National COVID-19 trends, August 27
-
These are the drag artists and organizers fighting to make queer spaces more COVID safe
-
Outdoor dining fades as pandemic persists — making public spaces even less accessible
Health
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
Work until you disappear: Long COVID ensnared me in an exploitative health system
-
We must free Long COVID and the people living with it from the mind-body trap
-
Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis